Complete Filing Data
Charging Robotics Inc. reported Stockholders Equity of $1.59 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Charging Robotics Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Net Income * | -$387.0K | -$842.0K | -$804.0K | -$810.0K | -$17.5K | $5.8K | -$2.7M | -$2.5M |
| Cost of Revenue * | $597.7K | $754.0K | ||||||
| Operating Income Loss | -$1.9M | -$777.0K | -$766.0K | -$753.0K | -$28.8K | -$5.1K | -$2.7M | -$2.5M |
| General And Administrative Expense | $1.2M | $458.0K | $437.0K | $71.0K | $5.5K | $1.8K | ||
| Operating Expenses | $1.9M | $777.0K | $766.0K | $753.0K | $28.8K | $5.1K | $2.8M | $2.5M |
| Research And Development Expense | $652.0K | $319.0K | $329.0K | $682.0K | ||||
| Interest Expense | $59.0K | $12.0K | -$4.0K | $5.0K | $37.2K | $8.8K | ||
| Comprehensive Income Net Of Tax | -$643.0K | -$845.0K | -$819.0K | -$833.0K | ||||
| Other Nonoperating Income Expense | $49.0K | -$29.0K | -$11.0K | $24.00 | $423.00 | |||
| Other Comprehensive Income Loss Net Of Tax | -$263.0K | -$3.0K | -$15.0K | -$23.0K | ||||
| Income Loss From Equity Method Investments | -$42.0K | -$36.0K | -$27.0K | |||||
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | ||||||||
| Sales Revenue Net | $775.2K | $780.1K | ||||||
| Nonoperating Income Expense | -$37.2K | -$8.3K | ||||||
| Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest | -$102.2K | -$17.5K | $5.8K | |||||
| Gross Profit | $177.5K | $26.2K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2012 | Q2 2012 | Q1 2012 | Q4 2011 | Q3 2011 | Q2 2011 | Q1 2011 | Q3 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$492.0K | $930.0K | -$234.0K | -$199.0K | -$184.0K | -$198.0K | -$286.0K | -$191.0K | -$53.0K | -$285.0K | -$188.0K | -$11.3K | -$2.8K | -$3.0K | -$3.3K | -$305.00 | $10.2K | -$239.00 | -$101.4K | -$296.3K | -$298.0K | -$1.1M | -$760.9K | -$723.8K | -$429.5K | -$500.3K |
| Cost of Revenue * | $73.0K | $91.7K | $154.8K | $177.5K | $241.0K | $210.6K | $207.1K | |||||||||||||||||||
| Operating Income Loss | -$556.0K | -$261.0K | -$221.0K | -$185.0K | -$180.0K | -$182.0K | -$272.0K | -$181.0K | -$52.0K | -$252.0K | -$183.0K | -$11.3K | -$2.8K | -$3.0K | -$3.3K | -$305.00 | -$677.00 | -$239.00 | -$238.8K | -$275.2K | -$278.4K | -$767.3K | -$712.6K | -$426.5K | -$500.7K | |
| General And Administrative Expense | $434.0K | $188.0K | $149.0K | $107.0K | $95.0K | $119.0K | $127.0K | $144.0K | $12.0K | $39.0K | $32.0K | $1.3K | $1.2K | $1.5K | $1.7K | $305.00 | $677.00 | $239.00 | $160.2K | $109.4K | ||||||
| Operating Expenses | $556.0K | $261.0K | $221.0K | $185.0K | $180.0K | $182.0K | $52.0K | $37.1K | $14.2K | $11.3K | $2.8K | $3.0K | $3.3K | $305.00 | $677.00 | $239.00 | $271.5K | $297.2K | $345.1K | $783.0K | $745.9K | $559.8K | $537.2K | |||
| Research And Development Expense | $122.0K | $73.0K | $72.0K | $78.0K | $85.0K | $63.0K | $145.0K | $37.0K | $40.0K | $213.0K | $151.0K | $47.8K | ||||||||||||||
| Interest Expense | $21.0K | $49.0K | -$2.0K | $13.0K | $2.0K | $1.0K | $29.2K | $21.1K | $19.5K | $17.5K | $11.2K | $3.0K | ||||||||||||||
| Comprehensive Income Net Of Tax | -$492.0K | $929.0K | -$223.0K | -$198.0K | -$185.0K | -$200.0K | -$306.0K | -$198.0K | -$53.0K | -$284.0K | -$207.0K | |||||||||||||||
| Other Nonoperating Income Expense | -$26.0K | -$58.0K | -$9.0K | -$7.0K | $1.0K | $2.0K | $5.00 | $13.00 | $6.00 | $421.00 | ||||||||||||||||
| Other Comprehensive Income Loss Net Of Tax | -$1.0K | $11.0K | $1.0K | -$1.0K | -$2.0K | -$20.0K | -$7.0K | $1.0K | ||||||||||||||||||
| Income Loss From Equity Method Investments | -$38.0K | -$4.0K | -$7.0K | -$5.0K | -$18.0K | -$14.0K | -$10.0K | |||||||||||||||||||
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | -$582.0K | $968.0K | -$192.0K | -$179.0K | -$272.0K | -$181.0K | -$784.8K | -$500.3K | ||||||||||||||||||
| Sales Revenue Net | $105.7K | $113.7K | $221.4K | $193.3K | $274.3K | $344.0K | $243.5K | |||||||||||||||||||
| Nonoperating Income Expense | $137.4K | -$21.1K | -$19.5K | $6.4K | -$11.2K | -$3.0K | $421.00 | |||||||||||||||||||
| Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest | -$11.3K | -$3.3K | ||||||||||||||||||||||||
| Gross Profit | $32.7K | $22.0K | $66.7K | $15.7K | $33.3K | $133.4K | $36.4K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $1.6M | -$613.0K | -$174.0K | -$442.0K | $450.0K | -$12.6K | -$20.5K | $20.3K | $393.1K | $398.0K |
| Retained Earnings Accumulated Deficit | -$3.3M | -$2.9M | -$2.1M | -$1.2M | -$1.6M | -$1.5M | -$3.0M | |||
| Liabilities Current | $2.3M | $913.0K | $348.0K | $703.0K | $18.9K | $12.6K | $495.5K | |||
| Liabilities And Stockholders Equity | $9.1M | $332.0K | $223.0K | $384.0K | $0.00 | $0.00 | $1.5M | |||
| Liabilities | $3.9M | $945.0K | $397.0K | $752.0K | $18.9K | $12.6K | $1.1M | |||
| Assets | $9.1M | $332.0K | $223.0K | $384.0K | $0.00 | $0.00 | $1.5M | |||
| Common Stock Value | $1.0K | $1.0K | $1.0K | $25.7K | $3.7K | $800.00 | ||||
| Accounts Payable Current | $125.0K | $81.0K | $104.0K | $108.0K | $18.9K | $4.9K | $334.2K | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $58.0K | $175.0K | $8.0K | $27.0K | $167.0K | |||||
| Assets Current | $255.0K | $259.0K | $51.0K | $98.0K | $1.5M | |||||
| Cash And Cash Equivalents At Carrying Value | $175.0K | $8.0K | $27.0K | $25.6K | ||||||
| Investments In Affiliates Subsidiaries Associates And Joint Ventures | $34.0K | $73.0K | $110.0K | $152.0K | $217.0K | |||||
| Assets Noncurrent | $8.8M | $73.0K | $172.0K | $286.0K | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$117.0K | $167.0K | -$19.0K | |||||||
| Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax | -$27.0K | -$12.0K | ||||||||
| Accounts And Other Receivables Net Current | $197.0K | $20.0K | $43.0K | $71.0K | ||||||
| Other Liabilities Current | $810.0K | $247.0K | $116.0K | |||||||
| Intangible Assets Net Excluding Goodwill | $7.0M | $74.0K | ||||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | |||||||
| Property Plant And Equipment Net | $2.0K | $3.8K | ||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$19.0K | -$140.0K | ||||||||
| Notes Payable Current | ||||||||||
| Inventory Net | $1.4M | |||||||||
| Other Liabilities Noncurrent | $36.0K | $32.0K | $49.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2018 | Q3 2012 | Q2 2012 | Q1 2012 | Q4 2011 | Q3 2011 | Q2 2011 | Q1 2011 | Q4 2010 | Q3 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $2.4M | $2.8M | -$531.0K | -$634.0K | -$438.0K | -$373.0K | -$174.0K | $170.0K | $393.0K | -$421.0K | -$291.0K | -$843.0K | -$30.1K | -$10.5K | -$18.9K | -$15.9K | -$8.7K | -$8.4K | -$20.8K | -$10.2K | -$240.9K | -$142.9K | $120.4K | $189.5K | -$273.1K | $393.1K | ||||||
| Retained Earnings Accumulated Deficit | -$2.7M | -$2.2M | -$3.1M | -$2.5M | -$2.3M | -$2.2M | -$1.7M | -$1.5M | -$1.7M | -$1.6M | -$1.6M | -$1.6M | -$1.5M | -$1.5M | -$1.5M | -$1.8M | -$1.7M | -$1.4M | -$1.1M | -$293.4K | ||||||||||||
| Liabilities Current | $1.5M | $1.4M | $959.0K | $874.0K | $709.0K | $509.0K | $190.0K | $138.0K | $65.1K | $190.4K | $117.5K | $31.4K | $10.5K | $18.9K | $15.9K | $1.6M | $1.6M | $1.4M | $1.4M | $1.4M | ||||||||||||
| Liabilities And Stockholders Equity | $7.6M | $7.6M | $460.0K | $271.0K | $302.0K | $285.0K | $409.0K | $580.0K | $78.8K | $109.0K | $73.2K | $1.2K | $0.00 | $0.00 | $0.00 | $1.4M | $1.5M | $1.5M | $1.6M | $1.6M | ||||||||||||
| Liabilities | $1.6M | $1.4M | $991.0K | $905.0K | $740.0K | $558.0K | $239.0K | $187.0K | $65.1K | $190.4K | $117.5K | $31.4K | $10.5K | $18.9K | $15.9K | $1.6M | $1.6M | $1.4M | $1.4M | $1.8M | ||||||||||||
| Assets | $7.6M | $7.6M | $460.0K | $271.0K | $302.0K | $285.0K | $409.0K | $580.0K | $78.8K | $109.0K | $73.2K | $1.2K | $0.00 | $0.00 | $0.00 | $1.4M | $1.5M | $1.5M | $1.6M | $1.6M | ||||||||||||
| Common Stock Value | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $137.0K | $137.0K | $31.4K | $31.4K | $25.7K | $25.7K | $25.7K | $25.7K | $3.7K | $3.7K | $1.5K | $1.4K | $1.3K | $1.3K | $1.2K | |||||||||||
| Accounts Payable Current | $121.0K | $104.0K | $91.0K | $92.0K | $103.0K | $129.0K | $74.0K | $27.4K | $4.0K | $11.4K | $1.2K | $2.2K | $1.7K | $236.4K | $343.5K | $344.1K | $474.4K | $382.7K | ||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $47.0K | $114.0K | $281.0K | $6.0K | $38.0K | $111.0K | $254.0K | $3.2K | $120.0K | $5.0K | $1.2K | |||||||||||||||||||||
| Assets Current | $169.0K | $208.0K | $389.0K | $25.0K | $52.0K | $28.0K | $157.0K | $301.0K | $78.8K | $109.0K | $73.2K | $1.2K | $0.00 | $0.00 | $1.3M | $1.4M | $1.5M | $1.5M | $1.5M | |||||||||||||
| Cash And Cash Equivalents At Carrying Value | $6.0K | $38.0K | $111.0K | $254.0K | $3.2K | $109.0K | $73.2K | $1.2K | $7.0K | $1.0K | $495.00 | $4.8K | $213.3K | $76.0K | $11.6K | $82.1K | ||||||||||||||||
| Investments In Affiliates Subsidiaries Associates And Joint Ventures | $71.0K | $78.0K | $83.0K | $90.0K | $106.0K | $133.0K | ||||||||||||||||||||||||||
| Assets Noncurrent | $7.4M | $7.4M | $71.0K | $246.0K | $250.0K | $257.0K | $252.0K | $279.0K | ||||||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$67.0K | -$165.0K | $97.0K | -$32.0K | $38.0K | -$8.0K | -$27.0K | |||||||||||||||||||||||||
| Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax | -$20.0K | -$20.0K | -$19.0K | -$30.0K | -$29.0K | -$30.0K | -$29.0K | -$32.0K | -$19.0K | |||||||||||||||||||||||
| Accounts And Other Receivables Net Current | $122.0K | $26.0K | $33.0K | $19.0K | $14.0K | $28.0K | $46.0K | |||||||||||||||||||||||||
| Other Liabilities Current | $443.0K | $345.0K | $299.0K | $197.0K | $161.0K | $137.0K | $43.0K | $22.0K | ||||||||||||||||||||||||
| Intangible Assets Net Excluding Goodwill | $104.0K | $104.0K | $104.0K | $100.0K | $85.0K | $85.0K | $74.0K | |||||||||||||||||||||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||||||||||
| Property Plant And Equipment Net | $2.0K | $2.0K | $25.3K | $27.5K | $29.6K | $31.8K | $34.0K | |||||||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$103.9K | $1.2K | ||||||||||||||||||||||||||||||
| Notes Payable Current | $73.0K | $66.0K | $595.0K | $5.0K | $5.0K | $5.0K | $26.0K | |||||||||||||||||||||||||
| Inventory Net | $68.0K | $705.4K | $773.0K | $784.4K | $793.7K | $947.2K | ||||||||||||||||||||||||||
| Other Liabilities Noncurrent | $36.0K | $35.0K | $32.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Increase Decrease In Accounts Payable | $9.0K | -$23.0K | -$69.0K | $93.0K | $13.9K | -$13.1K | $116.4K | $70.3K |
| Net Cash Provided By Used In Operating Activities | -$1.1M | -$610.0K | -$644.0K | -$612.0K | -$5.7K | -$2.3M | -$3.1M | |
| Net Cash Provided By Used In Financing Activities | $934.0K | $777.0K | $622.0K | $535.0K | $5.7K | $2.4M | $3.1M | |
| Net Cash Provided By Used In Investing Activities | $2.0K | $3.0K | -$63.0K | -$36.8K | -$4.8K | |||
| Increase Decrease In Accounts And Other Receivables | $102.0K | -$23.0K | -$28.0K | $31.0K | ||||
| Proceeds From Issuance Of Private Placement | $306.0K | $410.0K | $501.0K | $173.0K | ||||
| Increase Decrease In Other Accounts Payable And Accrued Liabilities | $435.0K | $131.0K | $116.0K | $25.0K | ||||
| Share Based Compensation | -$4.0K | $10.0K | $15.0K | |||||
| Increase Decrease In Due From Related Parties | -$46.0K | -$74.0K | -$52.0K | |||||
| Proceeds From Short Term Debt | $638.0K | $367.0K | $30.0K | $26.0K | $101.7K | |||
| Increase Decrease In Accounts Payable Related Parties | $3.0K | -$2.6K | -$9.2K | |||||
| Stock Issued During Period Value Share Based Compensation | -$4.0K | $10.0K | $15.0K | |||||
| Proceeds From Stock Options Exercised | $91.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2012 | Q4 2011 | Q1 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Increase Decrease In Accounts Payable | $48.0K | $8.0K | $10.0K | -$11.0K | -$26.0K | $25.0K | -$53.0K | -$7.5K | -$3.2K | $239.00 | -$103.4K | -$169.9K | |
| Net Cash Provided By Used In Operating Activities | -$375.0K | -$168.0K | -$198.0K | -$143.0K | -$133.0K | -$99.0K | -$66.0K | -$18.7K | -$368.9K | -$498.7K | |||
| Net Cash Provided By Used In Financing Activities | $308.0K | $1.0K | $295.0K | $111.0K | $171.0K | $95.0K | $39.0K | $20.0K | $369.5K | $564.4K | |||
| Net Cash Provided By Used In Investing Activities | $2.0K | -$4.0K | -$75.0K | -$1.5K | |||||||||
| Increase Decrease In Accounts And Other Receivables | $28.0K | -$14.0K | $13.0K | $5.0K | -$14.0K | -$15.0K | -$26.0K | ||||||
| Proceeds From Issuance Of Private Placement | $1.0K | $255.0K | $500.0K | ||||||||||
| Increase Decrease In Other Accounts Payable And Accrued Liabilities | $238.0K | -$200.0K | $52.0K | $36.0K | $24.0K | $21.0K | $12.0K | ||||||
| Share Based Compensation | $1.0K | $2.0K | $1.0K | ||||||||||
| Increase Decrease In Due From Related Parties | $162.0K | -$277.0K | $15.0K | -$15.0K | -$30.0K | -$18.0K | |||||||
| Proceeds From Short Term Debt | $308.0K | $91.0K | $106.0K | $95.0K | |||||||||
| Increase Decrease In Accounts Payable Related Parties | $6.6K | ||||||||||||
| Stock Issued During Period Value Share Based Compensation | $1.0K | $20.0K | $1.0K | $210.0K | |||||||||
| Proceeds From Stock Options Exercised |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.04 | -$0.09 | -$0.10 | -$30.54 | -$0.27 | -$0.31 | ||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Authorized | 50.0M | 50.0M | 2.99B | 2.99B | 2.99B | 290.0M | 215.0M | |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 43.0M | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Outstanding | 11.2M | 9.6M | 9.2M | 27.3K | 256.7M | 36.7M | 8.0M | |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common Stock Shares Issued | 11.2M | 9.6M | 9.2M | 27.3K | 256.7M | 36.7M | 8.0M | |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Weighted Average Number Of Shares Outstanding Basic | 10.5M | 9.2M | 7.8M | 27.3K | ||||
| Earnings Per Share Basic | $-0.09 | $-0.10 | $-30.54 | |||||
| Weighted Average Number Of Common Shares Outstanding Basic And Diluted | 9.9M | 8.0M | ||||||
| Debt Conversion Converted Instrument Shares Issued1 | 220.0M | 22.0M | ||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2012 | Q2 2012 | Q1 2012 | Q4 2011 | Q3 2011 | Q2 2011 | Q1 2011 | Q3 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.04 | $0.09 | -$0.02 | -$0.02 | -$0.02 | -$0.02 | -$0.03 | -$0.02 | -$291.21 | -$10.49 | -$7.59 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$0.01 | -$0.02 | -$0.02 | -$0.08 | -$0.09 | -$0.05 | -$0.06 | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||
| Common Stock Shares Authorized | 50.0M | 2.99B | 2.99B | 2.99B | 2.99B | 2.99B | 2.99B | 2.99B | 3.00B | 290.0M | 290.0M | 290.0M | 290.0M | 290.0M | 215.0M | 215.0M | 215.0M | 215.0M | 215.0M | |||||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 43.0M | 43.0M | 43.0M | 43.0M | 43.0M | |||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| Common Stock Shares Outstanding | 11.2M | 11.2M | 9.8M | 9.2M | 9.2M | 9.2M | 1.37B | 1.37B | 314.4M | 256.7M | 256.7M | 256.7M | 256.7M | 36.7M | 36.7M | 14.7M | 14.4M | 13.3M | 13.0M | 12.5M | ||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||
| Common Stock Shares Issued | 11.2M | 11.2M | 9.8M | 9.2M | 9.2M | 9.2M | 1.37B | 1.37B | 256.7M | 256.7M | 256.7M | 256.7M | 36.7M | 36.7M | 14.7M | 14.4M | 13.3M | 13.0M | 12.5M | |||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||
| Weighted Average Number Of Shares Outstanding Basic | 11.2M | 9.9M | 9.6M | 9.2M | 9.2M | 9.2M | 9.2M | 8.1M | 182.00 | 27.3K | 27.3K | 256.7M | 242.2M | 36.7M | 36.7M | |||||||||||
| Earnings Per Share Basic | $-0.02 | $-0.02 | $-0.02 | $-0.02 | $-0.03 | $-0.02 | $-291.21 | $-10.45 | $-7.59 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||||
| Weighted Average Number Of Common Shares Outstanding Basic And Diluted | 14.4M | 14.1M | 13.0M | 10.1M | 8.0M | 8.0M | 8.5M | |||||||||||||||||||
| Debt Conversion Converted Instrument Shares Issued1 | ||||||||||||||||||||||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 256.7M | 36.7M | 36.7M | 36.7M | 36.7M | 36.7M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Additional Paid In Capital | $5.2M | $2.3M | $741.0K | $1.5M | $1.5M | $3.4M | ||
| Stock Issued During Period Value New Issues | $256.0K | $410.0K | $501.0K | $173.0K | $11.2K | $2.2K | ||
| Professional Fees | $95.3K | $23.3K | $3.3K | |||||
| Short Term Borrowings | $1.2M | $413.0K | $30.0K | |||||
| Due To Related Parties Current | $3.0K | $2.6K | $2.5K | |||||
| Advertising Expense | $1.2M | $967.9K | ||||||
| Share In Losses Of Affiliate | -$27.0K | -$42.0K | ||||||
| Reserve From Sharebased Compensation Transactions | $2.3M | $1.9M | $91.0K | |||||
| Other Cost And Expense Operating | $1.6M | $1.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q2 2020 | Q3 2012 | Q2 2012 | Q1 2012 | Q4 2011 | Q3 2011 | Q2 2011 | Q1 2011 | Q3 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Additional Paid In Capital | $5.2M | $5.0M | $2.6M | $1.8M | $1.8M | $1.8M | $1.8M | $1.7M | $1.7M | $1.5M | $1.5M | $1.5M | $1.5M | $1.5M | $1.5M | $1.5M | $1.5M | $1.5M | $1.3M | $19.0K | |||||
| Stock Issued During Period Value New Issues | $1.0K | $255.0K | $11.2K | $2.2K | |||||||||||||||||||||
| Professional Fees | $37.5K | $36.4K | $12.4K | $10.0K | $1.6K | $1.5K | $1.7K | $194.4K | $34.9K | ||||||||||||||||
| Short Term Borrowings | $801.0K | $472.0K | $412.0K | $340.0K | $234.0K | $127.0K | |||||||||||||||||||
| Due To Related Parties Current | $9.4K | $11.7K | $9.2K | $1.9K | $1.9K | $1.9K | $1.9K | ||||||||||||||||||
| Advertising Expense | -$4.1K | $36.4K | $395.00 | $294.1K | $356.6K | $349.7K | $107.7K | ||||||||||||||||||
| Share In Losses Of Affiliate | -$18.0K | -$14.0K | -$10.0K | -$1.0K | -$33.0K | -$5.0K | |||||||||||||||||||
| Reserve From Sharebased Compensation Transactions | $123.0K | $122.0K | $102.0K | $100.0K | |||||||||||||||||||||
| Other Cost And Expense Operating | $275.6K | $260.9K | $344.7K | $488.9K | $389.3K | $210.2K |
Most recent annual filing with the SEC: March 23, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.